Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1728-1738
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1728
Table 1 Comparison of general data of two groups, n (%)
General information
Control group (n = 57)
Observation group (n = 63)
χ2/t
P value
Gender0.0630.802
Male41 (71.93)44 (69.84)
Female16 (28.07)19 (30.16)
Age [ (mean ± SD), age]57.79 ± 9.2856.70 ± 11.270.570.57
BMI [ (mean ± SD), kg/m2]23.43 ± 3.7323.17 ± 3.060.4330.666
Type of disease0.020.887
Rectal cancer21 (36.84)24 (38.10)
Colon cancer36 (63.16)39 (61.90)
Maximum diameter of metastatic lesion [(mean ± SD), cm]3.46 ± 0.943.39 ± 0.980.3980.691
Number of liver metastatic lesions
120 (35.09)23 (36.51)0.0360.982
219 (33.33)21 (33.33)
≥ 318 (31.58)19 (30.16)
Surgical program [n (%)]0.30.956
Partial hepatectomy21 (36.84)24 (38.10)
Segmentectomy16 (28.07)15 (23.81)
Lobectomy14 (24.56)17 (26.98)
Other6 (10.53)7 (11.11)
Table 2 Comparison of postoperative recovery between two groups (mean ± SD)
Group
n
Exhaust time (hour)
Defecation time (hour)
Eating time (day)
Drainage time (day)
Postoperative hospital stay (day)
Control group5742.56 ± 10.2366.36 ± 15.231.96 ± 0.278.25 ± 1.6314.12 ± 3.13
Observation group6331.54 ± 8.6749.93 ± 9.771.48 ± 0.326.58 ± 1.4412.03 ± 2.87
t6.3847.18.8315.9593.816
P value00000
Table 3 Comparison of T lymphocyte subsets between the two groups (mean ± SD)
GroupnCD3+ (μL)
CD4+ (μL)
CD8+ (μL)
CD4+/CD8+
Preoperative
3 d after operation
Preoperative
3 d after operation
Preoperative
3 d after operation
Preoperative
3 d after operation
Control group571214.36 ± 256.361108.33 ± 241.25a859.63 ± 210.36778.52 ± 189.69a658.52 ± 187.25736.33 ± 214.05a1.36 ± 0.251.07 ± 0.36a
Observation group631197.68 ± 267.331163.69 ± 287.11867.44 ± 225.59842.52 ± 200.13a647.96 ± 193.24665.36 ± 204.781.34 ± 0.281.28 ± 0.34a
t0.3481.1370.1961.7930.3031.8560.4113.286
P value0.7280.2580.8450.0760.7620.0660.6820.001
Table 4 Comparison of medical coping style scores between two groups [ (mean ± SD), fraction]
Group
n
Face
Avoid
Yield
Before intervention
After intervention
Before intervention
After intervention
Before intervention
After intervention
Control group5718.36 ± 3.2321.04 ± 3.34a20.36 ± 3.1516.89 ± 2.44a14.96 ± 2.7711.25 ± 1.93a
Observation group6317.78 ± 3.2624.15 ± 2.06a21.05 ± 3.3414.12 ± 2.05a15.12 ± 2.1610.01 ± 1.27a
t0.9786.2021.1616.7540.3554.195
P value0.3300.24800.7240
Table 5 Comparison of the life function index scale scores between two groups [ (mean ± SD), fraction]
GroupnGood bodyPsychologically soundDifficulty due to cancer
Before interventionAfter interventionBefore interventionAfter interventionBefore interventionAfter intervention
Control group5740.58 ± 3.9641.35 ± 4.2324.02 ± 3.3625.26 ± 3.07a12.23 ± 2.0912.75 ± 2.26
Observation group6341.07 ± 3.7546.96 ± 3.87a23.87 ± 3.4126.89 ± 3.31a12.14 ± 2.2812.83 ± 2.07
t0.6967.5870.2422.7880.2250.202
P value0.48800.8090.0060.8230.84
GroupnGood societyNauseaTotal score of FLIC
Before interventionAfter interventionBefore interventionAfter interventionBefore interventionAfter intervention
Control group5710.26 ± 1.3810.87 ± 1.473.05 ± 1.143.11 ± 1.0581.89 ± 4.5693.34 ± 5.16a
Observation group6310.19 ± 1.4412.68 ± 1.51a2.97 ± 1.213.23 ± 1.1180.74 ± 4.61102.96 ± 6.44a
t0.2716.640.3720.6071.3728.869
P value0.78700.7110.5450.1730
Table 6 Comparison of complications between the two groups, n (%)
Group
n
Incision infection
Pleural effusion
Intestinal obstruction
Celiac hemorrhage
Cumulative
Control group573 (5.26)3 (5.26)1 (1.75)1 (1.75)8 (14.04)
Observation group631 (1.59)1 (1.59)0 (0.00)0 (0.00)2 (3.17)
χ24.621
P value0.032
Table 7 Comparison of nursing satisfaction between the two groups, n (%)
Group
n
discontent
satisfied
Very satisfied
Satisfaction rate
Control group5711 (19.30)23 (40.36)23 (40.36)46 (80.70)
Observation group634 (6.35)29 (46.03)30 (47.62)59 (93.65)
χ26.666
P value0.01